Healthspan Underwriting & Longevity Insurance Services Market Size, Share, Growth and Forecast (2026 - 2036)

What is the healthspan underwriting & longevity insurance services market forecast to be worth by 2036?

USD 1.5 billion in 2026 to USD 29.6 billion by 2036, at 34.7% CAGR.

• The healthspan underwriting and longevity insurance services market crossed a valuation of USD 1.1 billion in 2025.
• Demand is expected to increase from USD 1.5 billion in 2026 to USD 29.6 billion by 2036.
• The market is forecast to record 34.7% CAGR during 2026 to 2036 as insurers test verified health behavior and pension sponsors price longer-life exposure.

What are the defining numbers behind healthspan underwriting and longevity insurance services growth?

USD 28.1 billion absolute opportunity by 2036, led by China and the United Kingdom.

• Demand Drivers in the Market
  • Life insurers need verified health behavior evidence before adjusting underwriting classes.
  • Pension sponsors need longevity analytics when member survival assumptions change liabilities.
  • Reinsurers need model validation before accepting biological-age or wearable-linked risk signals.
  • Employers need group benefits that connect protection cover with measurable health engagement.
• Key Segments Analyzed
  • By Delivery Model: Insurer Embedded delivery is projected to hold 44.0% share in 2026 because large carriers prefer services inside their own policy and compliance systems.
  • By Product Model: Shared-Value Insurance accounts for 41.0% share in 2026 because rewards can be tied to verified health actions and policyholder engagement.
  • By End Use: Individual Life is expected to hold 40.0% share in 2026 because retail life products provide the clearest link between health behavior and pricing.
  • By Service Type: Healthspan Analytics is expected to hold 34.0% share in 2026 because insurers need structured evidence before healthspan signals affect underwriting
  • By Data Source: Wearable Data holds 38.0% share in 2026 because activity feeds are easier to verify than one-time lab panels.
  • By Buyer Type: Life Insurers are likely to account for 36.0% share in 2026 because underwriting teams decide how evidence changes risk classes.
  • By Geography: China is expected to advance at 37.2% CAGR through 2036 as insurance premium scale and digital channels support pilots.
• Analyst Opinion at Fact.MR
  • Shambhu Nath Jha of Fact.MR states, “Healthspan underwriting is becoming a pricing evidence service. Buyers are not paying for wellness slogans. They are paying for data permission and model proof that improves risk selection. They also need evidence that protects fairness and can survive regulator review.”
• Strategic Implications
  • Life insurers should test healthspan evidence through opt-in programs before changing core underwriting rules.
  • Pension sponsors need mortality and morbidity assumptions that can be explained to trustees and regulators.
  • Reinsurers should build validation playbooks for wearable and biological-age variables.
  • Analytics providers need consent workflows because consumer trust decides whether the model can scale.

Services that turn wearable, biomarker and longevity data into underwriting evidence form the core of this market. National Association of Insurance Commissioners activity on insurer use of AI systems supports closer review of model governance. This pushes buyers to use auditable insurance analytics rather than informal wellness scores.

China is expected to advance at 37.2% CAGR through 2036 as insurance premium scale and app-led channels support health-linked products. The United Kingdom is projected to expand at 36.4% CAGR because pension risk transfer activity creates demand for longevity analytics. The United States is forecast to record 35.8% CAGR as life insurers test wellness-linked underwriting. South Korea is expected to post 35.2% CAGR as insurers combine health apps with rewards. Japan is projected to reach 34.9% CAGR because SUMITOMO LIFE Vitality has already built a shared-value insurance base.

How does the healthspan underwriting & longevity insurance services market break down by segment?

Insurer Embedded delivery leads at 44.0%. Shared-Value Insurance follows with 41.0% share in 2026.

Which service type dominates?

Healthspan Analytics holds 34.0% share in 2026.

Healthspan Analytics is expected to hold 34.0% share in 2026 because insurers need a structured way to convert healthspan signals into underwriting inputs. The work covers variable selection, scoring rules and model review. It also sits close to wearable AI when activity, sleep and heart-rate signals are used for risk classification.

Which data source dominates?

Wearable Data holds 38.0% share in 2026.

Wearable Data is projected to account for 38.0% share in 2026 because activity and engagement feeds can be collected more often than lab results. Programs such as John Hancock Vitality show how insurers connect verified health actions with policy rewards. The data layer also depends on wireless health and fitness devices that keep customers engaged between policy reviews.

Which buyer type dominates?

Life Insurers hold 36.0% share in 2026.

Life Insurers are forecast to hold 36.0% share in 2026 because they control underwriting manuals and pricing rules. This buyer group also manages customer consent when healthspan data enters insurance decisions. Large life and health insurance carriers therefore become the first institutional buyers for integrated programs.

Which product model dominates?

Shared-Value Insurance holds 41.0% share in 2026.

Shared-Value Insurance is likely to capture 41.0% share in 2026 because it links policyholder rewards with verified health behavior. Discovery Vitality and John Hancock Vitality show that engagement can sit inside life insurance. This model gives insurers a commercial route before biological-age pricing becomes routine.

Which delivery model dominates?

Insurer Embedded delivery holds 44.0% share in 2026.

Insurer Embedded delivery is estimated to hold 44.0% share in 2026 because carriers prefer underwriting evidence inside existing policy workflows. This reduces rework for compliance teams and advisers. It also links healthspan evidence with policy administration systems used for issue, billing and customer servicing.

Which end use dominates?

Individual Life holds 40.0% share in 2026.

Individual Life is expected to account for 40.0% share in 2026 because customers can see a direct link between health actions and policy rewards. Group life remains important but decisions pass through employers and brokers. Individual policies allow insurers to test opt-in data permission with clearer customer communication.

What is accelerating healthspan underwriting demand, and what is holding it back?

Wearable-linked insurance and pension longevity exposure support demand. Data permission and bias review restrain wider use.

Insurers are testing verified behavior-based pricing because health data can improve risk selection when consent is clear. John Hancock’s Vitality program shows how rewards can make customer data sharing more acceptable. Behavior-linked insurance also borrows lessons from usage-based insurance, where customers share data when benefits are visible and terms are clear.

Pension risk transfer adds another source of demand because sponsors need stronger assumptions for long-life exposure. Pension funds and insurers use longevity analytics before buy-in, buyout and swap transactions. This creates paid work for actuarial teams and insurance consulting services that can connect mortality evidence with transfer pricing.

Expansion is limited by governance risk when healthspan scores affect pricing or access. European insurance guidance treats life and health pricing models as sensitive use cases. Providers therefore need consent workflows, bias testing and audit-ready model documentation before healthspan variables can influence underwriting classes.

Where do the biggest healthspan underwriting opportunities sit?

Shared-value life insurance, pension transfer analytics and consent-led biological-age scoring.

• Shared-Value Life Insurance: Carriers can expand opt-in programs that connect health actions with rewards and cover design.
• Pension Transfer Analytics: Pension fund trustees can use longevity evidence when preparing buy-in and buyout transactions.
• Biological-Age Scoring: Reinsurers can validate lab and epigenetic variables before insurers use them in underwriting.

Which countries are scaling healthspan underwriting & longevity insurance services fastest?

China leads at 37.2%. The United Kingdom follows at 36.4%. The United States records 35.8%. South Korea reaches 35.2%. Japan posts 34.9%. Australia stands at 34.1%. Germany follows at 33.6%.

Based on regional analysis, the Healthspan Underwriting & Longevity Insurance Services Market covers North America, Western Europe, East Asia, South Asia and Pacific, Latin America, and the Middle East and Africa.

What is powering China’s expansion?

37.2% CAGR, supported by insurance premium scale and app-led health engagement.

China has a large insurance base that can support app-led healthspan programs. The National Financial Regulatory Administration reported RMB 6.1 trillion of primary insurance premium income in 2025. China is expected to advance at 37.2% CAGR through 2036 as insurers test health-linked engagement inside large digital ecosystems. Ping An Health and China Life give suppliers local channels for rewards, health services and policy servicing. Providers that can localize consent and model governance are better placed here.

Why does the United Kingdom matter?

36.4% CAGR, backed by pension risk transfer and longevity-risk analytics.

The United Kingdom is an early market for pension de-risking and mortality analytics. The Pension Protection Fund reported a GBP 14 billion reserve that underwrites about GBP 1 trillion of liabilities in remaining defined benefit schemes. The United Kingdom is projected to expand at 36.4% CAGR through 2036 because pension trustees need evidence before transferring long-life exposure. Legal & General, Aviva and Just Group support a local buyer base for advisory and analytics providers. Supplier access depends on trustee confidence and insurer balance-sheet capacity.

What supports the United States outlook?

35.8% CAGR, supported by life insurer pilots and model governance review.

The United States has the deepest commercial life insurance base for wellness-linked underwriting tests. The Centers for Disease Control and Prevention reported U.S. life expectancy at birth of 79.0 years for 2024. The United States is forecast to record 35.8% CAGR through 2036 as carriers combine mortality data, customer rewards and underwriting analytics. John Hancock and Prudential Financial create visible local proof for opt-in healthspan programs. Buyers need explainable models because state regulators are reviewing insurer use of external data.

How is South Korea positioned?

35.2% CAGR, supported by health apps and insurer-linked wellness programs.

South Korea has high digital insurance usage and strong customer familiarity with mobile health services. Korean Re reported the Korean insurance market profile for the first half of 2024 and showed continued life and health underwriting focus. South Korea is expected to post 35.2% CAGR through 2036 as insurers connect health engagement, rewards and reinsurance validation. Samsung Life and Hanwha Life provide local routes for program testing. Supplier success depends on privacy handling and insurer system integration.

Why is Japan an important market?

34.9% CAGR, supported by shared-value insurance and older-age protection needs.

Japan combines long life expectancy with a large domestic life insurance sector. Sumitomo Life reported about 1.5 million SUMITOMO LIFE Vitality members as of March 2025. Japan is projected to reach 34.9% CAGR through 2036 because insurers can build on existing shared-value insurance experience. Nippon Life and Sumitomo Life give suppliers local partners with scale and trust. Japan may grow slightly below China because underwriting change is slower and distribution is more adviser-led.

What underpins Australia’s demand?

34.1% CAGR, supported by superannuation assets and group insurance links.

Australia matters because retirement savings and group insurance are closely connected through superannuation. The Australian Prudential Regulation Authority reported AUD 4.4 trillion in total superannuation assets as of March 2026. Australia is forecast to grow at 34.1% CAGR through 2036 as funds and insurers review longevity, disability and wellbeing evidence. TAL, MLC Life Insurance and AIA Australia provide local channels for program design. Adoption is constrained by conduct rules and member consent expectations.

How does Germany perform?

33.6% CAGR, supported by insurance governance and biometric risk expertise.

Germany offers a cautious but technically deep market for underwriting analytics. Munich Re and Hannover Re give the country a strong reinsurance base. Germany is expected to expand at 33.6% CAGR through 2036 as carriers use actuarial review before introducing healthspan variables. Allianz, Munich Re and Hannover Re support the local supplier base. Growth is lower than the global rate because data protection and product approval cycles slow implementation.

Who leads the healthspan underwriting & longevity insurance services landscape?

Discovery Limited, John Hancock and Sumitomo Life lead behavior-linked insurance proof. Prudential Financial, Pacific Life Re and Legal & General lead longevity-risk transfer depth.

Discovery Limited and John Hancock have the clearest behavior-linked life insurance evidence through Vitality-based products. Sumitomo Life adds Japan-specific scale through SUMITOMO LIFE Vitality. These companies help buyers understand how verified health behavior can be linked to policy rewards without turning underwriting into a one-time medical test.

Prudential Financial, Pacific Life Re and Legal & General compete through longevity-risk transfer and pension de-risking work. Their role is different from wellness programs because they price liabilities over decades. This makes reinsurance capability a core part of the provider landscape.

YuLife competes through group risk and employee benefits. Its platform shows how engagement can sit inside employer-paid protection. Smaller insurtech firms need actuarial validation and carrier partnerships before they can win larger contracts.

Which companies are the key players?

Discovery Limited and John Hancock lead wellness-linked insurance activity. YuLife and Sumitomo Life also compete in this field. Prudential Financial, Pacific Life Re and Legal & General support longevity-risk transfer.

• Discovery Limited (Vitality)
• John Hancock Life Insurance Company
• YuLife Ltd.
• Sumitomo Life Insurance Company
• Prudential Financial, Inc.
• Pacific Life Re Limited
• Legal & General Group Plc

Bibliography

• [1] Xu, J. Q., Murphy, S. L., Kochanek, K. D., & Arias, E. (2026, January 29). Mortality in the United States, 2024 (NCHS Data Brief No. 548). National Center for Health Statistics.
• [2] Office for National Statistics. (2025, December 10). National life tables – life expectancy in the UK: 2022 to 2024.
• [3] Organisation for Economic Co-operation and Development. (2025, November 13). Life expectancy and healthy life expectancy at older ages. In Health at a Glance 2025: OECD indicators. OECD Publishing.
• [4] National Association of Insurance Commissioners. (2026, April 1). Implementation of NAIC Model Bulletin: Use of Artificial Intelligence Systems by Insurers.
• [5] European Insurance and Occupational Pensions Authority. (2025, August 6). Opinion on artificial intelligence governance and risk management.
• [6] Pension Protection Fund. (2025, December 4). PPF publishes 20th edition of The Purple Book.
• [7] Australian Prudential Regulation Authority. (2026, May 28). APRA releases superannuation statistics for March 2026.
• [8] National Financial Regulatory Administration. (2026, February 12). Supervisory statistics of the banking and insurance sectors: 2025 Q4.
• [9] Financial Services Agency. (2025, December 15). Overview of financial results of major life insurance companies as of September 30, 2025.
• [10] Korean Re. (2024, October–December). Korean insurance market: Preliminary business results of insurers in Korea for the first half of 2024. In Korean Re Bulletin No. 193.
• [11] John Hancock Life Insurance Company. (2024, November 21). John Hancock adds new Apple Watch Series 10 to its Vitality Program.
• [12] John Hancock Life Insurance Company. (2025, May 12). John Hancock marks 10 years of helping customers live longer, healthier, better lives since launch of industry-leading Vitality Program.
• [13] John Hancock Life Insurance Company. (2026, January 29). John Hancock unveils GenAI-based underwriting support tool: Quick Quote.
• [14] YuLife Ltd. (2025, July 14). YuLife launches new wellbeing add-ons to expand group risk offering.
• [15] Prudential Financial, Inc. (2025, August 8). Prudential awarded $4 billion international longevity risk transfer transaction.
• [16] Pacific Life Re Limited. (2025, February 20). Pacific Life Re announces longevity swap reinsurance agreement with Nationale-Nederlanden Life.
• [17] Legal & General Group Plc. (2025, October 27). L&G completes £4.6 billion buy-in with Ford pension schemes.
• [18] Discovery Limited. (2025, September 10). Audited annual financial results for the year ended 30 June 2025.
• [19] Sumitomo Life Insurance Company. (2025, June 20). FY2024 business results.
• [20] Kannampuzha, S., & Kissoyan, K. A. (2024, February 15). Epigenetic testing – The way ahead for life & health underwriting? Gen Re.

This Report Addresses

• Strategic intelligence on healthspan underwriting and longevity insurance services across service type, data source and buyer type.
• Segment analysis covering Healthspan Analytics and Wearable Data. It also covers Life Insurers, Shared-Value Insurance and Insurer Embedded delivery.
• Regional outlook covering China and the United Kingdom. It also covers the United States and South Korea. Japan, Australia and Germany complete the country view.
• Competitive analysis covers Discovery Limited, John Hancock, YuLife, Sumitomo Life, Prudential Financial, Pacific Life Re, and Legal & General.
• Service assessment covering biological-age analytics and wearable pricing. It also covers longevity transfer and model governance.
• Primary interviews and official data review support the forecast. Provider checks and pension risk transfer validation complete the evidence base.

What does the healthspan underwriting & longevity insurance services market cover?

Underwriting, analytics and longevity-risk services that price insurance or pensions using verified healthspan evidence.

The healthspan underwriting and longevity insurance services market covers paid services that help insurers and reinsurers price risk with verified healthspan evidence. It also helps pension funds and employers use healthspan signals in benefit decisions. The scope includes biological-age analytics and wearable-linked life insurance services. It also includes pension longevity-risk transfer analytics. The market differs from insurance premiums because the service focus is pricing evidence and model governance.

What is included in the scope?

Healthspan analytics, wearable-linked underwriting and pension longevity modelling.

The scope includes healthspan scoring, biological-age testing interpretation and underwriting governance. It covers wearable pricing support and shared-value insurance program design. It includes pension longevity analytics and advisory work tied to risk transfer. It also includes carrier integration with policy systems and reinsurer validation.

What is excluded from the scope?

Insurance premiums, pension assets and wellness programs without underwriting or risk-transfer use.

The scope excludes life insurance premium pools unless a paid analytics or advisory fee is attached. It excludes pension fund assets under management. It excludes consumer wellness apps that do not support pricing or risk review. It also excludes medical testing revenue that is not connected to insurance or pension decisions.

How was the analysis built?

120+ sources and 50+ company portfolios. Coverage included 30+ countries and 25+ interviews.

• Primary Research: Primary research includes interviews with insurance product teams and underwriting leaders. It includes input from pension risk advisers and reinsurer analytics teams.
• Desk Research: Desk research reviews insurance regulator documents and official pension statistics. It covers wellness-linked insurance pages and longevity-risk transfer disclosures.
• Market-Sizing and Forecasting: Forecasting uses provider revenue pools and addressable insurance accounts. Biological-age pilots and pension transfer activity support the market assessment.
• Data Validation and Update Cycle: Forecasts are validated through provider checks and policy activity signals. Regulatory updates and company launches help confirm market direction.